Latest News Archive

Please select Category, Year, and then Month to display items
Years
2017 2018 2019 2020
Previous Archive
03 April 2019 | Story Xolisa Mnukwa | Photo Vhugala Nthakheni
Uhuru Qwaqwa Arrival
The #UFSWalkToUhuru team arrives at the UFS Qwaqwa Campus on Friday 22 March.

The University of the Free State (UFS) Division of Student Affairs, in collaboration with the UFS Office for International Affairs, have joined hands to drive a fundraising and student-accessibility initiative dubbed, ‘The Walk to Uhuru’ (#UFSWalktoUhuru), which is aimed at raising funds and advocating for the educational rights of the less privileged. 

The project aims to raise funds in excess of R2 million from the public and stakeholders affiliated with the UFS (Kovsie staff and students). The project derives from the 2018/2019 UFS Institutional Student Representative Council (ISRC) mandate ‘Students Must Graduate’. The ISRC mandate aims to source funding opportunities for UFS students to register, and to complete their studies across all three campuses in 2020 and beyond.

The first leg of the project, a 350 km walk from the Bloemfontein to the Qwaqwa Campus, has already taken place and concluded on Friday, 22 March 2019 as planned. The #UFSWalkToUhuru team successfully completed the first leg of their journey to academic freedom for financially disadvantaged students at the UFS. The Uhuru team is now focusing its attention on the second leg and is determined to take on Mount Kilimanjaro (Uhuru) from 20 June to 20 July 2019.

The team sat down for a debriefing session to unpack the overall experience and result of the first half of the initiative, and they all agreed that the walk to Qwaqwa was an enlightening experience. It was a walk that comprised learning opportunities, team building, and goal crushing.

According to Rethabile Motseki, member of the #UFSWalkToUhuru team, the walk to Qwaqwa made a significant impact on the project, as the university community is now aware of the significant goals that the team is trying to accomplish. The team has also resumed their fitness-training programme to ensure that they are ready to take on the Uhuru climb in June.

A media briefing will take place shortly (date to be confirmed) to detail the ongoing fundraising initiatives rolled out by the #UFSWalkToUhuru team.  We implore you, and the nation as a whole, to help establish a better future for disadvantaged UFS students by donating to the initiative.

Students, staff, and the public can support the cause and make contributions/donations to the initiative by visiting the UFS Walk to Uhuru #givengain account page.

For more information, contact UFS SRC President, Sonwabile Dwaba, on DwabaSJ@ufs.ac.za  or Rethabile Motseki on MotsekiR@ufs.ac.za  

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept